البلد: كندا
اللغة: الإنجليزية
المصدر: Health Canada
TENOXICAM
AA PHARMA INC
M01AC02
TENOXICAM
20MG
TABLET
TENOXICAM 20MG
ORAL
250ML
Prescription
OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS
Active ingredient group (AIG) number: 0122416001; AHFS:
APPROVED
2022-09-01
_TENOXICAM (Tenoxicam Tablets) _ _Page 1 of 31_ PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR TENOXICAM Tenoxicam Tablets Tablets, 20 mg and Oral House Standard Anti-inflammatory, Analgesic Agent AA PHARMA INC. 1165 Creditstone Road, Unit #1 Vaughan, Ontario L4K 4N7 www.aapharma.ca Submission Control Number: 266573 Date of Initial Authorization: June 09, 2010 Date of Revision: AUG 31, 2022 _ _ _TENOXICAM (Tenoxicam Tablets) _ _Page 2 of 31_ RECENT MAJOR LABEL CHANGES 2 Contraindications 3 Serious Warnings and Precautions Box 7 Warnings and Precautions 7 Warnings and Precautions, 7.1.1 Pregnant Women 08/2022 TABLE OF CONTENTS SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF AUTHORIZATION ARE NOT LISTED. RECENT MAJOR LABEL CHANGES ........................................................................................... 2 TABLE OF CONTENTS ............................................................................................................. 2 PART I: HEALTH PROFESSIONAL INFORMATION ..................................................................... 4 1 INDICATIONS .............................................................................................................. 4 1.1 Pediatrics ................................................................................................................... 4 1.2 Geriatrics ................................................................................................................... 4 2 CONTRAINDICATIONS ................................................................................................. 4 3 SERIOUS WARNINGS AND PRECAUTIONS BOX ............................................................ 5 4 DOSAGE AND ADMINISTRATION ................................................................................. 5 4.2 Recommended Dose and Dosage Adjustment ......................................................... 5 4.5 Missed Dose ................................................................................................. اقرأ الوثيقة كاملة